Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olatz Arrizabalaga

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Aging|April 4, 2020
Elevated p38MAPK activity promotes neural stem cell agingLeire Moreno-Cugnon, Olatz Arrizabalaga, Irantzu Llarena, et al.
Journal of Medical Internet Research|October 3, 2022
Tracking Openness and Topic Evolution of COVID-19 Publications January 2020-March 2021: Comprehensive Bibliometric and Topic Modeling AnalysisMaider San Torcuato, Núria Bautista-Puig, Olatz Arrizabalaga, et al.
F1000Research|August 29, 2020
Open Access of COVID-19-related publications in the first quarter of 2020: a preliminary study based in PubMedOlatz Arrizabalaga, David Otaegui, Itziar Vergara, et al.
Aging Cell|May 21, 2015
Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional declineEstefania Carrasco-Garcia, Olatz Arrizabalaga, Manuel Serrano, et al.
Recent Patents on Anti-Cancer Drug Discovery|April 24, 2013
Therapeutic strategies targeting glioblastoma stem cellsEstefania Carrasco-Garcia, Nicolas Sampron, Paula Aldaz, et al.
Aging Cell|September 28, 2019
Neuronal p38α mediates age-associated neural stem cell exhaustion and cognitive declineLeire Moreno-Cugnon, Miren Revuelta, Olatz Arrizabalaga, et al.
Frontiers in Oncology|November 9, 2016
Targeting SOX2 as a Therapeutic Strategy in GlioblastomaLaura Garros-Regulez, Idoia Garcia, Estefania Carrasco-Garcia, et al.
Expert Opinion on Therapeutic Targets|February 16, 2016
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistanceLaura Garros-Regulez, Paula Aldaz, Olatz Arrizabalaga, et al.
Oncogenesis|December 30, 2017
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor responseOlatz Arrizabalaga, Leire Moreno-Cugnon, Jaione Auzmendi-Iriarte, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Aging|April 4, 2020
Elevated p38MAPK activity promotes neural stem cell agingLeire Moreno-Cugnon, Olatz Arrizabalaga, Irantzu Llarena, et al.
Journal of Medical Internet Research|October 3, 2022
Tracking Openness and Topic Evolution of COVID-19 Publications January 2020-March 2021: Comprehensive Bibliometric and Topic Modeling AnalysisMaider San Torcuato, Núria Bautista-Puig, Olatz Arrizabalaga, et al.
F1000Research|August 29, 2020
Open Access of COVID-19-related publications in the first quarter of 2020: a preliminary study based in PubMedOlatz Arrizabalaga, David Otaegui, Itziar Vergara, et al.
Aging Cell|May 21, 2015
Increased gene dosage of Ink4/Arf and p53 delays age-associated central nervous system functional declineEstefania Carrasco-Garcia, Olatz Arrizabalaga, Manuel Serrano, et al.
Recent Patents on Anti-Cancer Drug Discovery|April 24, 2013
Therapeutic strategies targeting glioblastoma stem cellsEstefania Carrasco-Garcia, Nicolas Sampron, Paula Aldaz, et al.
Aging Cell|September 28, 2019
Neuronal p38α mediates age-associated neural stem cell exhaustion and cognitive declineLeire Moreno-Cugnon, Miren Revuelta, Olatz Arrizabalaga, et al.
Frontiers in Oncology|November 9, 2016
Targeting SOX2 as a Therapeutic Strategy in GlioblastomaLaura Garros-Regulez, Idoia Garcia, Estefania Carrasco-Garcia, et al.
Expert Opinion on Therapeutic Targets|February 16, 2016
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistanceLaura Garros-Regulez, Paula Aldaz, Olatz Arrizabalaga, et al.
Oncogenesis|December 30, 2017
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor responseOlatz Arrizabalaga, Leire Moreno-Cugnon, Jaione Auzmendi-Iriarte, et al.
Pageof 1